Free Trial

UnitedHealth Group (UNH) Competitors

UnitedHealth Group logo
$407.45 +11.83 (+2.99%)
Closing price 03:59 PM Eastern
Extended Trading
$407.20 -0.25 (-0.06%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

UNH vs. ALKS, MEDP, CI, CNC, and CVS

Should you buy UnitedHealth Group stock or one of its competitors? UnitedHealth Group's main competitors and comparable companies include Alkermes (ALKS), Medpace (MEDP), Cigna Group (CI), Centene (CNC), and CVS Health (CVS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does UnitedHealth Group compare to Alkermes?

UnitedHealth Group (NYSE:UNH) and Alkermes (NASDAQ:ALKS) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

Alkermes has a net margin of 3.96% compared to UnitedHealth Group's net margin of 3.53%. UnitedHealth Group's return on equity of 17.95% beat Alkermes' return on equity.

Company Net Margins Return on Equity Return on Assets
UnitedHealth Group3.53% 17.95% 5.95%
Alkermes 3.96%4.15%2.19%

87.9% of UnitedHealth Group shares are owned by institutional investors. Comparatively, 95.2% of Alkermes shares are owned by institutional investors. 0.2% of UnitedHealth Group shares are owned by insiders. Comparatively, 4.6% of Alkermes shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

UnitedHealth Group has higher revenue and earnings than Alkermes. UnitedHealth Group is trading at a lower price-to-earnings ratio than Alkermes, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UnitedHealth Group$447.57B0.79$12.06B$15.5425.48
Alkermes$1.48B4.44$241.66M$0.38102.84

UnitedHealth Group has a beta of 0.6, indicating that its stock price is 40% less volatile than the broader market. Comparatively, Alkermes has a beta of 0.32, indicating that its stock price is 68% less volatile than the broader market.

In the previous week, UnitedHealth Group had 103 more articles in the media than Alkermes. MarketBeat recorded 107 mentions for UnitedHealth Group and 4 mentions for Alkermes. UnitedHealth Group's average media sentiment score of 0.79 beat Alkermes' score of 0.48 indicating that UnitedHealth Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
UnitedHealth Group
55 Very Positive mention(s)
15 Positive mention(s)
25 Neutral mention(s)
6 Negative mention(s)
1 Very Negative mention(s)
Positive
Alkermes
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

UnitedHealth Group presently has a consensus target price of $461.83, suggesting a potential upside of 16.62%. Alkermes has a consensus target price of $54.47, suggesting a potential upside of 39.38%. Given Alkermes' stronger consensus rating and higher possible upside, analysts plainly believe Alkermes is more favorable than UnitedHealth Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
UnitedHealth Group
0 Sell rating(s)
8 Hold rating(s)
20 Buy rating(s)
0 Strong Buy rating(s)
2.71
Alkermes
1 Sell rating(s)
5 Hold rating(s)
11 Buy rating(s)
2 Strong Buy rating(s)
2.74

Summary

UnitedHealth Group beats Alkermes on 9 of the 17 factors compared between the two stocks.

How does UnitedHealth Group compare to Medpace?

UnitedHealth Group (NYSE:UNH) and Medpace (NASDAQ:MEDP) are both large-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, media sentiment, valuation and risk.

87.9% of UnitedHealth Group shares are held by institutional investors. Comparatively, 78.0% of Medpace shares are held by institutional investors. 0.2% of UnitedHealth Group shares are held by insiders. Comparatively, 20.5% of Medpace shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Medpace has a net margin of 17.67% compared to UnitedHealth Group's net margin of 3.53%. Medpace's return on equity of 110.15% beat UnitedHealth Group's return on equity.

Company Net Margins Return on Equity Return on Assets
UnitedHealth Group3.53% 17.95% 5.95%
Medpace 17.67%110.15%24.84%

UnitedHealth Group presently has a consensus target price of $461.83, suggesting a potential upside of 16.62%. Medpace has a consensus target price of $607.73, suggesting a potential downside of 1.44%. Given UnitedHealth Group's stronger consensus rating and higher possible upside, research analysts clearly believe UnitedHealth Group is more favorable than Medpace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
UnitedHealth Group
0 Sell rating(s)
8 Hold rating(s)
20 Buy rating(s)
0 Strong Buy rating(s)
2.71
Medpace
0 Sell rating(s)
10 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.23

UnitedHealth Group has higher revenue and earnings than Medpace. UnitedHealth Group is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UnitedHealth Group$447.57B0.79$12.06B$15.5425.48
Medpace$2.78B6.19$451.12M$17.0636.14

UnitedHealth Group has a beta of 0.6, suggesting that its share price is 40% less volatile than the broader market. Comparatively, Medpace has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market.

In the previous week, UnitedHealth Group had 98 more articles in the media than Medpace. MarketBeat recorded 107 mentions for UnitedHealth Group and 9 mentions for Medpace. UnitedHealth Group's average media sentiment score of 0.79 beat Medpace's score of 0.62 indicating that UnitedHealth Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
UnitedHealth Group
55 Very Positive mention(s)
15 Positive mention(s)
25 Neutral mention(s)
6 Negative mention(s)
1 Very Negative mention(s)
Positive
Medpace
5 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

UnitedHealth Group and Medpace tied by winning 8 of the 16 factors compared between the two stocks.

How does UnitedHealth Group compare to Cigna Group?

Cigna Group (NYSE:CI) and UnitedHealth Group (NYSE:UNH) are both large-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and media sentiment.

Cigna Group has a beta of 0.29, meaning that its stock price is 71% less volatile than the broader market. Comparatively, UnitedHealth Group has a beta of 0.6, meaning that its stock price is 40% less volatile than the broader market.

UnitedHealth Group has a net margin of 3.53% compared to Cigna Group's net margin of 2.27%. Cigna Group's return on equity of 19.75% beat UnitedHealth Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Cigna Group2.27% 19.75% 5.34%
UnitedHealth Group 3.53%17.95%5.95%

87.0% of Cigna Group shares are owned by institutional investors. Comparatively, 87.9% of UnitedHealth Group shares are owned by institutional investors. 0.6% of Cigna Group shares are owned by company insiders. Comparatively, 0.2% of UnitedHealth Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Cigna Group currently has a consensus price target of $338.24, suggesting a potential upside of 16.81%. UnitedHealth Group has a consensus price target of $461.83, suggesting a potential upside of 16.62%. Given Cigna Group's higher possible upside, research analysts plainly believe Cigna Group is more favorable than UnitedHealth Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cigna Group
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65
UnitedHealth Group
0 Sell rating(s)
8 Hold rating(s)
20 Buy rating(s)
0 Strong Buy rating(s)
2.71

Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.2%. UnitedHealth Group pays an annual dividend of $9.28 per share and has a dividend yield of 2.3%. Cigna Group pays out 25.8% of its earnings in the form of a dividend. UnitedHealth Group pays out 59.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cigna Group has raised its dividend for 5 consecutive years and UnitedHealth Group has raised its dividend for 15 consecutive years. UnitedHealth Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

UnitedHealth Group has higher revenue and earnings than Cigna Group. Cigna Group is trading at a lower price-to-earnings ratio than UnitedHealth Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cigna Group$281.34B0.27$5.96B$24.1711.98
UnitedHealth Group$447.57B0.79$12.06B$15.5425.48

In the previous week, UnitedHealth Group had 95 more articles in the media than Cigna Group. MarketBeat recorded 107 mentions for UnitedHealth Group and 12 mentions for Cigna Group. UnitedHealth Group's average media sentiment score of 0.79 beat Cigna Group's score of 0.69 indicating that UnitedHealth Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cigna Group
7 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
UnitedHealth Group
55 Very Positive mention(s)
15 Positive mention(s)
25 Neutral mention(s)
6 Negative mention(s)
1 Very Negative mention(s)
Positive

Summary

UnitedHealth Group beats Cigna Group on 14 of the 19 factors compared between the two stocks.

How does UnitedHealth Group compare to Centene?

Centene (NYSE:CNC) and UnitedHealth Group (NYSE:UNH) are both large-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability and risk.

In the previous week, UnitedHealth Group had 84 more articles in the media than Centene. MarketBeat recorded 107 mentions for UnitedHealth Group and 23 mentions for Centene. Centene's average media sentiment score of 0.85 beat UnitedHealth Group's score of 0.79 indicating that Centene is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Centene
14 Very Positive mention(s)
3 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
UnitedHealth Group
55 Very Positive mention(s)
15 Positive mention(s)
25 Neutral mention(s)
6 Negative mention(s)
1 Very Negative mention(s)
Positive

Centene currently has a consensus target price of $70.05, indicating a potential downside of 0.02%. UnitedHealth Group has a consensus target price of $461.83, indicating a potential upside of 16.62%. Given UnitedHealth Group's stronger consensus rating and higher possible upside, analysts plainly believe UnitedHealth Group is more favorable than Centene.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Centene
2 Sell rating(s)
10 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.33
UnitedHealth Group
0 Sell rating(s)
8 Hold rating(s)
20 Buy rating(s)
0 Strong Buy rating(s)
2.71

93.6% of Centene shares are owned by institutional investors. Comparatively, 87.9% of UnitedHealth Group shares are owned by institutional investors. 0.4% of Centene shares are owned by insiders. Comparatively, 0.2% of UnitedHealth Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

UnitedHealth Group has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than UnitedHealth Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Centene$194.78B0.18-$6.67B-$10.44N/A
UnitedHealth Group$447.57B0.79$12.06B$15.5425.48

Centene has a beta of 1.13, meaning that its stock price is 13% more volatile than the broader market. Comparatively, UnitedHealth Group has a beta of 0.6, meaning that its stock price is 40% less volatile than the broader market.

UnitedHealth Group has a net margin of 3.53% compared to Centene's net margin of -2.51%. UnitedHealth Group's return on equity of 17.95% beat Centene's return on equity.

Company Net Margins Return on Equity Return on Assets
Centene-2.51% 12.12% 3.20%
UnitedHealth Group 3.53%17.95%5.95%

Summary

UnitedHealth Group beats Centene on 12 of the 16 factors compared between the two stocks.

How does UnitedHealth Group compare to CVS Health?

UnitedHealth Group (NYSE:UNH) and CVS Health (NYSE:CVS) are both large-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment and earnings.

UnitedHealth Group has higher revenue and earnings than CVS Health. CVS Health is trading at a lower price-to-earnings ratio than UnitedHealth Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UnitedHealth Group$447.57B0.79$12.06B$15.5425.48
CVS Health$402.07B0.29$1.77B$3.7823.92

UnitedHealth Group has a net margin of 3.53% compared to CVS Health's net margin of 1.18%. UnitedHealth Group's return on equity of 17.95% beat CVS Health's return on equity.

Company Net Margins Return on Equity Return on Assets
UnitedHealth Group3.53% 17.95% 5.95%
CVS Health 1.18%13.12%3.95%

UnitedHealth Group pays an annual dividend of $9.28 per share and has a dividend yield of 2.3%. CVS Health pays an annual dividend of $2.66 per share and has a dividend yield of 2.9%. UnitedHealth Group pays out 59.7% of its earnings in the form of a dividend. CVS Health pays out 70.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. UnitedHealth Group has increased its dividend for 15 consecutive years and CVS Health has increased its dividend for 4 consecutive years.

87.9% of UnitedHealth Group shares are held by institutional investors. Comparatively, 80.7% of CVS Health shares are held by institutional investors. 0.2% of UnitedHealth Group shares are held by insiders. Comparatively, 0.9% of CVS Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, UnitedHealth Group had 54 more articles in the media than CVS Health. MarketBeat recorded 107 mentions for UnitedHealth Group and 53 mentions for CVS Health. UnitedHealth Group's average media sentiment score of 0.79 beat CVS Health's score of 0.59 indicating that UnitedHealth Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
UnitedHealth Group
55 Very Positive mention(s)
15 Positive mention(s)
25 Neutral mention(s)
6 Negative mention(s)
1 Very Negative mention(s)
Positive
CVS Health
25 Very Positive mention(s)
8 Positive mention(s)
9 Neutral mention(s)
9 Negative mention(s)
1 Very Negative mention(s)
Positive

UnitedHealth Group currently has a consensus price target of $461.83, indicating a potential upside of 16.62%. CVS Health has a consensus price target of $107.80, indicating a potential upside of 19.23%. Given CVS Health's stronger consensus rating and higher possible upside, analysts clearly believe CVS Health is more favorable than UnitedHealth Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
UnitedHealth Group
0 Sell rating(s)
8 Hold rating(s)
20 Buy rating(s)
0 Strong Buy rating(s)
2.71
CVS Health
0 Sell rating(s)
3 Hold rating(s)
20 Buy rating(s)
0 Strong Buy rating(s)
2.87

UnitedHealth Group has a beta of 0.6, suggesting that its stock price is 40% less volatile than the broader market. Comparatively, CVS Health has a beta of 0.6, suggesting that its stock price is 40% less volatile than the broader market.

Summary

UnitedHealth Group beats CVS Health on 13 of the 17 factors compared between the two stocks.

Get UnitedHealth Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for UNH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UNH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UNH vs. The Competition

MetricUnitedHealth GroupHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$365.72B$10.45B$7.43B$23.13B
Dividend Yield2.46%2.61%2.52%3.70%
P/E Ratio23.2734.47274.9628.45
Price / Sales0.824.64608.7395.40
Price / Cash17.77115.8876.6836.37
Price / Book3.515.2110.324.72
Net Income$12.06B$315.68M$3.49B$1.07B
7 Day Performance9.96%0.56%-2.54%-0.07%
1 Month Performance8.38%-3.65%-6.87%-2.64%
1 Year Performance12.94%10.36%1.81%5.85%

UnitedHealth Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UNH
UnitedHealth Group
4.7459 of 5 stars
$407.45
+3.0%
$461.48
+13.3%
+10.1%$365.72B$447.57B23.27390,000
ALKS
Alkermes
3.2404 of 5 stars
$40.11
-3.2%
$54.47
+35.8%
+22.4%$6.73B$1.48B105.562,050
MEDP
Medpace
2.7222 of 5 stars
$602.70
-0.3%
$607.73
+0.8%
+19.3%$16.82B$2.53B35.336,200
CI
Cigna Group
4.7661 of 5 stars
$281.10
+0.9%
$338.24
+20.3%
-4.1%$74.28B$274.90B11.6367,700
CNC
Centene
3.6032 of 5 stars
$64.49
-0.8%
$70.05
+8.6%
+92.4%$31.86B$194.78BN/A61,100

Related Companies and Tools


This page (NYSE:UNH) was last updated on 10/15/2026 by MarketBeat.com Staff.
From Our Partners